Executing a Phase IIb Geographic Atrophy Trial

Explore how TFS HealthScience supported a fast-moving biopharma sponsor in the successful start-up of a complex geographic atrophy trial—across seven countries and under global disruption.

Global Start-up Expertise for Geographic Atrophy Clinical Trials

Running a Phase IIb trial for geographic atrophy (GA) presents unique challenges—from complex imaging and functional testing to high screen failure rates and the need for ophthalmology-specialized sites. In this exclusive case study, see how TFS provided full-service clinical operations and strategic oversight to navigate unpredictable conditions and deliver results.

Inside this case study:

• Key considerations for launching a geographic atrophy trial across multiple countries
• How to manage operational risk and maintain data quality during global disruptions
• What it takes to align sites under shifting protocol requirements
• How TFS enabled seamless study start-up with minimal burden on the sponsor

With deep retinal disease expertise and trusted global site partnerships, TFS helped ensure readiness, regulatory compliance, and smooth execution despite pandemic-era obstacles.

Learn more about our related services and resources:

TFS Ophthalmology